Cathay Biotech (China) Today
| 688065 Stock | 43.06 0.06 0.14% |
Performance8 of 100
| Odds Of DistressLess than 1
|
Cathay Biotech is trading at 43.06 as of the 18th of December 2024, a 0.14 percent increase since the beginning of the trading day. The stock's open price was 43.0. Cathay Biotech has a very small chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 29th of December 2022 and ending today, the 18th of December 2024. Click here to learn more.
Business Domain Materials | Category Basic Materials |
Cathay Biotech is entity of China. It is traded as Stock on SHG exchange. The company has 583.38 M outstanding shares. More on Cathay Biotech
Moving together with Cathay Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Cathay Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cathay Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cathay Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman CEO | Xiucai Liu | ||||
| Business Concentration | Commodity Chemicals, Materials, Basic Materials, Materials, Chemicals, Chemicals, Basic Materials (View all Sectors) | ||||
Cathay Biotech's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Cathay Biotech's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCathay Biotech can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cathay Biotech's financial leverage. It provides some insight into what part of Cathay Biotech's total assets is financed by creditors.
| |||||
Cathay Biotech (688065) is traded on Shanghai Stock Exchange in China and employs 1,803 people. Cathay Biotech is listed under Commodity Chemicals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 24.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cathay Biotech's market, we take the total number of its shares issued and multiply it by Cathay Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cathay Biotech operates under Chemicals sector and is part of Materials industry. The entity has 583.38 M outstanding shares.
Cathay Biotech generates positive cash flow from operations, but has no cash available
Check Cathay Biotech Probability Of Bankruptcy
Ownership AllocationCathay Biotech holds a total of 583.38 Million outstanding shares. Cathay Biotech shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.34 percent of Cathay Biotech outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cathay Ownership Details
Cathay Biotech Risk Profiles
Although Cathay Biotech's alpha and beta are two of the key measurements used to evaluate Cathay Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.59 | |||
| Semi Deviation | 2.37 | |||
| Standard Deviation | 4.04 | |||
| Variance | 16.31 |
Cathay Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cathay Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Other Information on Investing in Cathay Stock
Cathay Biotech financial ratios help investors to determine whether Cathay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cathay with respect to the benefits of owning Cathay Biotech security.